Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00954564 · ClinicalTrials.gov registry record
Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors
A clinical trial of Breast Cancer and Arthralgia, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 351
- Enrollment target
- 2
- Study locations
NCT00954564 is a study of Breast Cancer and Arthralgia that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 351 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT00954564, a study of Breast Cancer and Arthralgia, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 351 participants
- Enrollment target
- 2
- Study locations
Study Summary
RATIONALE: Gathering information over time about joint pain and stiffness from postmenopausal women with early-stage breast cancer who are receiving aromatase inhibitors may help doctors plan treatment and help patients live more comfortably. PURPOSE: This observational epidemiologic cohort is designed to study arthralgia, patient-reported outcomes, and medication adherence in postmenopausal women with early-stage breast cancer who are receiving aromatase inhibitors.
Conditions Studied
Interventions
- OTHER medical chart review
- OTHER questionnaire administration
- PROCEDURE assessment of therapy complications
- OTHER aromatase inhibition therapy - OBSERVATIONAL ONLY
Study Locations (2)
Tennessee
- Vanderbilt-Ingram Cancer Center - Nashville
- Vanderbilt-Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 351 participants |
| Start Date | 2009-06 |
| Est. Completion | 2014-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00954564
The ClinicalTrials.gov registry entry for NCT00954564 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 351 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (87% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which medical chart review is the first listed.
NCT00954564 reports 2 study locations spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00954564 about?
NCT00954564 is a clinical study titled "Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors". RATIONALE: Gathering information over time about joint pain and stiffness from postmenopausal women with early-stage breast cancer who are receiving aromatase inhibitors may help doctors plan treatment and help patients live more comfortably. PURPOSE: This observational epidemiologic cohort is desi...
What is the current status of trial NCT00954564?
This trial is currently completed. The enrollment target is 351 participants. The study started on 2009-06. Estimated completion is 2014-05.
What conditions does trial NCT00954564 study?
This clinical trial studies the following conditions: Breast Cancer, Arthralgia.
What interventions are being tested in trial NCT00954564?
The interventions under investigation include: medical chart review (OTHER), questionnaire administration (OTHER), assessment of therapy complications (PROCEDURE), aromatase inhibition therapy - OBSERVATIONAL ONLY (OTHER).
Who is sponsoring clinical trial NCT00954564?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00954564 being conducted?
This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.